|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/22/2013
|
MARIO ERNEST
|
Director
|
20,000
|
$5.49
|
200.00%
|
|
5/13/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
-1,014
|
$5.91
|
-1.01%
|
|
3/12/2013
|
Angotti Vincent
|
Executive VP, COO
|
-7,516
|
$7.73
|
-12.33%
|
|
3/12/2013
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-6,576
|
$7.73
|
-9.81%
|
|
3/12/2013
|
Harris William G
|
SVP, Finance and CFO
|
-7,516
|
$7.73
|
-7.38%
|
|
3/12/2013
|
Savello David R
|
SVP, Development
|
-7,516
|
$7.73
|
-9.99%
|
|
3/12/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
-6,468
|
$7.73
|
-6.23%
|
|
3/12/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
18,518
|
$2.70
|
21.73%
|
|
1/28/2013
|
Angotti Vincent
|
Executive VP, COO
|
-366
|
$8.48
|
-0.89%
|
|
1/28/2013
|
Harris William G
|
SVP, Finance and CFO
|
-366
|
$8.48
|
-0.45%
|
|
1/28/2013
|
Savello David R
|
SVP, Development
|
-320
|
$8.48
|
-0.58%
|
|
1/28/2013
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-206
|
$8.48
|
-0.41%
|
|
1/18/2013
|
Harris William G
|
SVP, Finance and CFO
|
15,000
|
$1.80
|
22.67%
|
|
1/14/2013
|
Angotti Vincent
|
Executive VP, COO
|
-3,291
|
$8.80
|
-7.54%
|
|
1/14/2013
|
BATES GREGORY T
|
SVP, Regulatory Affairs & QA
|
-1,645
|
$8.80
|
-12.43%
|
|
1/14/2013
|
BATES GREGORY T
|
SVP, Regulatory Affairs & QA
|
-2,194
|
$8.80
|
-13.23%
|
|
1/14/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
-4,380
|
$8.80
|
-6.47%
|
|
1/14/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
-6,056
|
$8.80
|
-7.61%
|
|
1/14/2013
|
Barrett Ronald W
|
Chief Executive Officer
|
-7,046
|
$8.80
|
-7.64%
|
|
1/14/2013
|
Angotti Vincent
|
Executive VP, COO
|
-548
|
$8.80
|
-1.67%
|
|
1/14/2013
|
Angotti Vincent
|
Executive VP, COO
|
-2,438
|
$8.80
|
-6.32%
|
|
1/14/2013
|
BATES GREGORY T
|
SVP, Regulatory Affairs & QA
|
-329
|
$8.80
|
-3.35%
|
|
1/14/2013
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-3,050
|
$8.80
|
-5.84%
|
|
1/14/2013
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-2,742
|
$8.80
|
-5.77%
|
|
1/14/2013
|
Savello David R
|
SVP, Development
|
-548
|
$8.80
|
-1.14%
|
|
1/14/2013
|
Savello David R
|
SVP, Development
|
-1,997
|
$8.80
|
-3.81%
|
|
1/14/2013
|
Savello David R
|
SVP, Development
|
-3,291
|
$8.80
|
-5.68%
|
|
1/14/2013
|
Harris William G
|
SVP, Finance and CFO
|
-548
|
$8.80
|
-0.93%
|
|
1/14/2013
|
Harris William G
|
SVP, Finance and CFO
|
-2,456
|
$8.80
|
-3.81%
|
|
1/14/2013
|
Harris William G
|
SVP, Finance and CFO
|
-3,291
|
$8.80
|
-4.74%
|
|
1/14/2013
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-329
|
$8.80
|
-0.79%
|
|
10/1/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-1,558
|
$11.43
|
-3.68%
|
|
8/10/2012
|
Angotti Vincent
|
Executive VP, COO
|
-917
|
$8.71
|
-3.06%
|
|
3/12/2012
|
Angotti Vincent
|
SVP & CCO
|
-3,668
|
$3.93
|
-11.77%
|
|
3/12/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-3,209
|
$3.93
|
-8.88%
|
|
3/12/2012
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-3,668
|
$3.93
|
-7.72%
|
|
3/12/2012
|
Harris William G
|
SVP, Finance and CFO
|
-3,668
|
$3.93
|
-6.12%
|
|
3/12/2012
|
Savello David R
|
SVP, Development
|
-3,668
|
$3.93
|
-7.28%
|
|
1/30/2012
|
Angotti Vincent
|
SVP & CCO
|
-418
|
$4.16
|
-1.94%
|
|
1/30/2012
|
Barrett Ronald W
|
Chief Executive Officer
|
-458
|
$4.16
|
-0.70%
|
|
1/30/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-235
|
$4.16
|
-0.85%
|
|
1/30/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-104
|
$4.16
|
-0.38%
|
|
1/30/2012
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-523
|
$4.16
|
-1.37%
|
|
1/30/2012
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-261
|
$4.16
|
-0.70%
|
|
1/30/2012
|
Harris William G
|
SVP, Finance and CFO
|
-418
|
$4.16
|
-0.83%
|
|
1/30/2012
|
Harris William G
|
SVP, Finance and CFO
|
-209
|
$4.16
|
-0.42%
|
|
1/30/2012
|
Savello David R
|
SVP, Development
|
-366
|
$4.16
|
-0.90%
|
|
1/30/2012
|
Savello David R
|
SVP, Development
|
-209
|
$4.16
|
-0.52%
|
|
1/13/2012
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-523
|
$4.34
|
-1.57%
|
|
1/13/2012
|
Harris William G
|
SVP, Finance and CFO
|
-2,617
|
$4.34
|
-5.06%
|
|
1/13/2012
|
Harris William G
|
SVP, Finance and CFO
|
-523
|
$4.34
|
-1.14%
|
|
1/13/2012
|
Savello David R
|
SVP, Development
|
-2,094
|
$4.34
|
-5.02%
|
|
1/13/2012
|
Savello David R
|
SVP, Development
|
-523
|
$4.34
|
-1.40%
|
|
1/13/2012
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-2,617
|
$4.34
|
-6.70%
|
|
1/13/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-314
|
$4.34
|
-1.33%
|
|
1/13/2012
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-2,617
|
$4.34
|
-8.86%
|
|
1/13/2012
|
Barrett Ronald W
|
Chief Executive Officer
|
-3,880
|
$4.34
|
-6.59%
|
|
1/13/2012
|
Barrett Ronald W
|
Chief Executive Officer
|
-6,805
|
$4.34
|
-9.55%
|
|
1/13/2012
|
Angotti Vincent
|
SVP & CCO
|
-523
|
$4.34
|
-3.00%
|
|
1/13/2012
|
Angotti Vincent
|
SVP & CCO
|
-2,617
|
$4.34
|
-11.29%
|
|
12/16/2011
|
RIEFLIN WILLIAM JL
|
Director
|
10,000
|
$3.86
|
3.69%
|
|
11/21/2011
|
RIEFLIN WILLIAM JL
|
Director
|
10,000
|
$4.44
|
3.83%
|
|
11/7/2011
|
RIEFLIN WILLIAM JL
|
Director
|
5,000
|
$5.49
|
1.95%
|
|
10/3/2011
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-1,558
|
$5.51
|
-6.38%
|
|
8/11/2011
|
Barrett Ronald W
|
Chief Executive Officer
|
7,500
|
$6.59
|
18.14%
|
|
8/10/2011
|
Angotti Vincent
|
SVP & CCO
|
-917
|
$6.45
|
-5.35%
|
|
7/18/2011
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
3,000
|
$1.50
|
10.32%
|
|
3/14/2011
|
Angotti Vincent
|
SVP & CCO
|
-3,688
|
$7.20
|
-20.14%
|
|
3/14/2011
|
Harris William G
|
SVP, Finance and CFO
|
-3,731
|
$7.20
|
-7.81%
|
|
3/14/2011
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-3,712
|
$7.20
|
-12.55%
|
|
3/14/2011
|
Savello David R
|
SVP, Development
|
-3,733
|
$7.20
|
-9.40%
|
|
3/14/2011
|
Bosko Gianna M
|
SVP, CAO, GC and secretary
|
-3,209
|
$7.20
|
-15.91%
|
|
1/31/2011
|
Savello David R
|
SVP, Development
|
-210
|
$7.88
|
-0.70%
|
|
1/31/2011
|
Barrett Ronald W
|
Chief Executive Officer
|
-458
|
$7.88
|
-1.19%
|
|
1/31/2011
|
Harris William G
|
SVP, Finance and CFO
|
-210
|
$7.88
|
-0.55%
|
|
1/31/2011
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-263
|
$7.88
|
-1.33%
|
|
1/28/2011
|
Angotti Vincent
|
SVP & CCO
|
-420
|
$7.80
|
-4.81%
|
|
1/28/2011
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-526
|
$7.80
|
-2.66%
|
|
1/28/2011
|
Harris William G
|
SVP, Finance and CFO
|
-420
|
$7.80
|
-1.11%
|
|
1/28/2011
|
Savello David R
|
SVP, Development
|
-368
|
$7.80
|
-1.24%
|
|
1/13/2011
|
Angotti Vincent
|
SVP & CCO
|
-526
|
$9.16
|
-6.37%
|
|
1/13/2011
|
Harris William G
|
SVP, Finance and CFO
|
-526
|
$9.16
|
-1.41%
|
|
1/13/2011
|
Cundy Kenneth C
|
SVP, Preclinical Development
|
-526
|
$9.16
|
-2.77%
|
|
1/13/2011
|
Savello David R
|
SVP, Development
|
-526
|
$9.16
|
-1.79%
|
|
1/13/2011
|
Barrett Ronald W
|
Chief Executive Officer
|
-4,170
|
$9.16
|
-10.04%
|